AstraZeneca, Rasi: “No vaccine for women under 40”

“Women, and especially women aged 40 and under, really don’t have to take AstraZeneca, not even the second dose, because there’s really no need for it.” So to the microphones of ‘In Vivavoce’ on Rai Radio 1 Guido Rasi, former executive director of the European Medicines Agency Ema and consultant to the extraordinary commissioner for the coronavirus emergency, General Francesco Paolo Figliuolo. Read also The expert, microbiologist at the University of Rome Tor Vergata, therefore hopes for the anti-Covid vaccine of the Anglo-Swedish company – already recommended today by the European Medicines Agency Aifa for preferential use in over 60s – not only a ‘stake’ relating to age, but also to gender. The vast majority of the very rare cases of abnormal thrombosis recorded following vaccination, in fact, concern young women. So for them double caution with AstraZeneca? “Absolutely yes – replies Rasi – Caution is especially for women”, especially under 40. “Cases in men are even more exceptional”. In young women, the former Ema number one advises against AstraZeneca also as a post first reminder dose: “We are moving towards a second dose, also heterologous – he underlines – I hope that the CTS”, the Technical Scientific Commission of Aifa, “will reach this conclusion because all the evidence is in favor. Indeed, probably” the mix between vaccines “is even more effective”.